In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
DNA Ginkgo Bioworks Holdings, Inc.
With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback